Prolongation of Progesterone Supplementation in Antagonist Cycles and Pregnancy Outcomes

Universitair Ziekenhuis Brussel200 enrolled

Overview

The objective of this study is to evaluate the effect of the prolongation of luteal support on the ongoing pregnancy rate (beyond 12 weeks of gestation )in recFSH/GnRH antagonist cycles.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

200

Conditions

Infertility

Interventions

progesteroneDRUG

duration

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 39 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age equal or less than 39 * Body mass index between 18-29 kg/m2 * Presence of both ovaries * Basal hormonal values on day 2 of the cycle * Embryotransfer day3 or day5 * 1 to 3 cycles Exclusion Criteria: * Endometriosis stage 3 * Polycystic ovarian syndrome * Frozen or testicular sperm

Outcomes

Primary Outcomes

ongoing pregnancy rate

Time frame: up to 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.